Astellas Pharma Inc. announced that Astellas has obtained marketing approval of their oral androgen receptor signaling inhibitor, XTANDI® capsules 40mg ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE